   
  
 
Date of submission: November 14, 2025 
  
To,                
The Secretary 
Listing Department 
BSE Limited 
Department of Corporate Services 
Phiroze Jeejeebhoy Towers,  
Dalal Street, Mumbai – 400 001 
Scrip Code –539551(EQ), 975516 & 976418 
To,                
The Secretary 
Listing Department 
National Stock Exchange of India Limited 
Exchange Plaza, Bandra Kurla Complex  
Mumbai – 400 051 
 
Scrip Code- NH 
 
Dear Sir/Madam, 
 
Sub: Investor Presentation for the quarter and half year ended September 30, 2025 
 
With reference to the subject, please find enclosed the Investor Presentation for the quarter and half 
year ended September 30, 2025. 
 
Kindly take the above information on record. 
 
Thanking you 
 
Yours faithfully 
For Narayana Hrudayalaya Limited 
 
 
 
 
 
Sridhar S. 
Group Company Secretary, Legal & Compliance Officer 
 
Encl.: as above 
 
August 02, 2023
Earnings Update 
Q2 FY26
2
Index
Our Footprint         03
Narayana Health at a Glance      04
Q2 FY26 Highlights        05 
Capex          14
Digital Transformation Initiatives     15
Narayana Health ESG Vision – “Health For All”  16
Shareholding Pattern                       17
Topic Slide No.
East
Hospitals - 7 | Clinics - 4| Dialysis Centre - 1
Operational beds -  2,030
West
Hospitals - 2
Operational beds - 354
As on 1st October 2025
Our Footprint
3
South
Hospitals - 6 | Heart Centres - 2 | Clinics - 14 | 
Diagnostic Centre - 1
Operational beds - 2,045 (Hospitals)
   - 132 (Heart Centres)
North
Hospitals – 3
Operational beds: 828
Mumbai
Kolkata
Ahmedabad
Raipur Jamshedpur
Guwahati
Shimoga
Bengaluru
Mysore
Delhi NCR
Jaipur
(1) Jammu unit is removed and is considered as a part of discontinued operation effective from FY25
Davanagere
 Facility Details No. of Facilities Operational Beds
 Owned / Operated Hospitals(1,3) 18 5,257
 Heart Centres 2 132
 Clinics and Dialysis Centre 20 0
 Cayman Islands 2 165
Healthcare Facilities 42 5,554
Total 18,718
Clinical : 11,512
Non-clinical : 7,206
7.1 Mn(2)
Average Effective Capital Cost per
Operational Bed
5,915
Capacity Beds
4,233
Doctors
(1) Owns the P&L responsibility
(2) Based on (Gross Block for Fixed Assets (adjusted for non-cash government grant provision impact, non-cash financial lease impact for Dharamshila unit, non-cash EPCG license impact )+ Capital Work in Progress (CWIP)) / Number of operational beds as 
of  Sept 30th, 2025, but excluding Cayman facility
(3) Jammu unit is removed and is considered as a part of discontinued operation effective from FY25
Narayana Health – At Glance
4
Key Highlights – Operational & Financial Performance (Q2 FY26)
Clinical & 
Operational
• Received the prestigious award for Clinical Governance from International Hospital Federation (IHF) and 
American college of Healthcare executives (ACHE) for Advancing Safety through Governance at their 
annual Congress in Geneva.
• Narayana Superspeciality Hospital, Howrah has:
• Commissioned a dual source 256 Slice CT Scan machine in the quarter
• Achieved a significant milestone of completing 1000+ Robotic surgeries
• Narayana Institute of Cardiac Sciences, Bangalore 
• Achieved its highest ever no of procedures across Robotic & Minimally Invasive Cardiac Surgery 
setting a national benchmark
• 97 Robotic cardiac surgeries in Sep’25 & 197 Robotic Surgeries for the quarter. 
• 420 Minimally Invasive Cardiac Surgery and 10 Percutaneous Pulmonary Valve Implantation. 
• Narayana Multi-specialty Hospital, Jaipur has expanded spectrum of quaternary care with Bone Marrow 
Transplant Services (BMT) in the quarter.
Financial 
Performance
• Consolidated operating revenues of ₹ 16,438 Mn in Q2 FY26, a change of +20.3% YoY and +9.1% QoQ.
• Consolidated EBITDA of ₹ 4,265 Mn in Q2 FY26 at a margin of 25.9% and consolidated PAT of ₹ 2,583 Mn 
for Q2 FY26 at a margin of 15.7%
• Consolidated Total Borrowings less Cash & Bank Balance and Investments of ₹ 2,466 Mn as on 30th 
September 2025, i.e. net debt to equity ratio of 0.06 (Out of which, debt worth US$ 69.0 Mn is foreign 
currency denominated).
5
5

India Operations – Revenue (Q2 FY26) 
Domestic
International Integrated Care - NHIC and NHIL
762
403
513
0
100
200
300
400
500
600
700
800
900
Q2 FY25 Q1 FY26 Q2 FY26
6
6
99
144
190
5
55
105
155
Q2 FY25 Q1 FY26 Q2 FY26
10,482 10,825 11,707 
 4
 5,004
 10,004
Q2 FY25 Q1 FY26 Q2 FY26
11,344 11,316 12,331 
 4
 5,004
 10,004
 15,004
Q2 FY25 Q1 FY26 Q2 FY26
Total*
11.7% YoY
-32.7% YoY 90.9% YoY
8.7% YoY
9.0% QoQ 8.1% QoQ
27.2% QoQ
32.1% QoQ
*Note - Total revenue is excluding Jammu, ATHMA, Medha and adjusted with Inter Company eliminations. Previous quarters numbers are adjusted for Jammu. 
₹ Mn
73%
25%
1%
0%
Owned Hospitals
Operated Hospitals
Heart Centres
Other Anciliary Businesses
47%
31%
18%
4%
Domestic Walk-in patients
Insured Patients
Schemes
International patients
Business Mix(4,7,8) Specialty-Profile(4,7,8) Payor-Profile(4,7,8) 
(1) NH owns on freehold basis and operates with the P&L responsibility    
(2) NH operates the hospitals on rental/revenue sharing basis and owns the P&L responsibility
(3) Includes clinics and dialysis centres excl. NHIC
(4) As percentage of operating revenue, excluding NHIC
(5) Insured Patients include Insurance-covered patients, corporate patients (including PSU’s on hospital tariff) 
(6) Schemes include CGHS, ESIS, other state government schemes
(7) Percentages might not add up to 100% due to rounding off
(8) Jammu unit is removed and is considered as a part of discontinued operation effective from FY25
33%
14%
15%
9%
7%
4%
16%
Cardiac Sciences Medicine and GI sciences
Oncology Renal Sciences
Neuro Sciences Orthopaedics
Others
India Hospital Operations – Revenue Mix (Q2 FY26) 
(1)
(3)
(2)
(6)
(5)
7
Operational Review – India Hospitals (Q2 FY26) 
ICU Occupied Bed Days
ALOS
Patient Footfalls (IP & OP)(1,3)
₹ ‘000 Days
‘000
OP
IP
664
617 662
59 53 58
0
100
200
300
400
500
600
700
Q2 FY25 Q1 FY26 Q2 FY26
(1) OP figures include day-care business.        
(2) ARPOB for the period Q2 FY26 was ₹ 17.5 Mn as against ₹ 15.3 Mn in Q2 FY25.
(3) Footfalls for IP correspond to Discharges.
(4) Jammu unit is removed and is considered as a part of discontinued operation effective from FY25. Previous quarter numbers are adjusted for Jammu.
8
8
‘000
4.5 4.8 4.8
136.4 148.7 149.4
Q2 FY25 Q1 FY26 Q2 FY26
Average Revenue Per Patient (IP & OP) (1,2)
OP
IP
101
85
96
60
70
80
90
100
110
Q2 FY25 Q1 FY26 Q2 FY26
4.5
4.3 4.3
3.7
3.9
4.1
4.3
4.5
4.7
Q2 FY25 Q1 FY26 Q2 FY26
Cluster Split – India Hospitals (Q2 FY26) This considers owned/operated hospitals & heart centers in India
(1) OP ARPP includes day care.
9% 7% 5%
36% 10% 10% 13%
% of Hospital 
Operating 
Revenues 
YoY Revenue 
Growth
OP ARPP(1)
(₹ ‘000)
YoY Hospital 
Discharges
Bangalore Southern 
Peripheral Kolkata Eastern
Peripheral Western Northern
Regions
5%
• NICS
• MSMC
• HSR
• Mysore
• Shimoga
• Davangere
• Dharwad
• Kolar
• RTIICS
• Barasat
• NMH
• NSH
• Jamshedpur
• Guwahati
• Raipur
• Mumbai
• Ahmedabad
• Gurugram
• New Delhi
• Jaipur
26%
9
4%
2%
-7% -4% 0%
IP ARPP 
(₹ ‘000)
5.0 3.7 4.5 4.1 4.3 4.6
198.3 67.9 121.4 114.7 128.3
5.6 4.1 4.5 4.2 4.0 4.8
232 79 151 133 120 124
2% -1% 4%
Capacity Beds 1498 797 1453 730 392 880
-2%
0%
9% 4%
10
Profitability Snapshot – India Hospitals (Q2 FY26) 
Excludes Jammu, NHIC, NHIL, ATHMA & MEDHA (2)
EBITDA and EBITDA Margin (1) Cost Structure
₹ ‘Mn % of Operating Revenues
(4) Consumable Expenses = Purchase of medical consumables, drugs and surgical equipment 
net of changes in inventories of medical consumables, drugs and surgical equipment
(5) Doctors and Nurses = Employee benefits + Professional fees to doctors
(6) Other Expenses = Overhead expenses + All other expenses 
(7) Effect of IND AS benefits is not considered
(1) Denotes EBITDA for entire India hospitals business excluding Jammu, NHIC, NHIL, ATHMA 
& MEDHA. EBITDA is without Dividend income.
(2) EBITDA for Q2 FY26 including NHIC, NHIL, ATHMA & MEDHA stood at ₹ 2,712 Mn (22.0%). 
EBITDA for NHIC and NHIL stood at -₹ 164 Mn for Q2 FY26.
(3) Previous quarter numbers are also adjusted for Jammu, NHIC, NHIL, ATHMA and MEDHA.
10
2,441 
2,309 
2,903 
21.7%
20.6%
23.8%Q2 FY25 Q1 FY26 Q2 FY26
18.0%
19.0%
20.0%
21.0%
22.0%
23.0%
24.0%
 1,500
 1,600
 1,700
 1,800
 1,900
 2,000
 2,100
 2,200
 2,300
 2,400
 2,500
Q2 FY25 Q1 FY26 Q2 FY26
(1)
28% 28% 27%
24% 24% 23%
17% 18% 17%
12% 11% 11%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Q2 FY25 Q1 FY26 Q2 FY26
Chart Title
Doctors and Nurses Consumable Expenses
Other Expenses Other Manpower Cost
Rental / Revenue Share (7)
2% 2%
(5)
(3)
(4)
2%
(2)(3)
11* 154,909* ₹155.77 Mn.*
As on 30th September 2025 Q2 FY26 Q2 FY26
Points of Presence Patient Transactions Revenue - Integrated Care 
Program running since September 2022 at select Bengaluru and Hosur locations
NH Integrated Care and Insurance: Snapshot
11
11
₹86.99 Mn.**
YTD Q2 FY26
GWP - Insurance
* Includes Integrated Care (Clinics) only.
** Gross written premium of NH Insurance
Expanding Group and Retail Insurance business nationally to markets having NH 
presence
Operational Review – Cayman Islands  (Q2 FY26) 
Hospital Revenues Insurance Revenues (CIHL)
Discharges Out-Patients
US$ Mn US$ Mn
12
0.6
5.3
9.3
0.0
2.0
4.0
6.0
8.0
10.0
Q2 FY25 Q1 FY26 Q2 FY26
8,819 
11,804 12,301 
 7,500
 8,500
 9,500
 10,500
 11,500
 12,500
 13,500
Q2 FY25 Q1 FY26 Q2 FY26
524 
738 
785 
 450
 550
 650
 750
 850
Q2 FY25 Q1 FY26 Q2 FY26
1) EBITDA of CIHL for Q2 FY 26 is US$ -0.3 Mn.
2) HCCI consol revenue to be adjusted for inter-co elimination of US$ 1.5 Mn in Q2 FY26.
29.2
42.6 41.6
24.0
29.0
34.0
39.0
44.0
Q2 FY25 Q1 FY26 Q2 FY26
Consolidated Financial Performance
Figures in ₹ Mn, unless stated otherwise
(1) Figures might not equal the reported numbers due to rounding off.
(2) Net Block includes non-cash government grant impact of ₹ 1,042 Mn, non-cash financial lease impact of ₹ 335 Mn and non-cash EPCG license impact of ₹ 371 Mn.
(3) Financial performance of NVDSHPL (Jammu) is not considered in the consolidated financial and has been disclosed as discontinued operations.
(4) Q2 FY 26 EBITDA is adjusted with one time acquisition related cost accrued in this quarter..
As on September 30th 2025, the Total Borrowings less Cash & Bank Balance and Investments was ₹ 2,466 Mn, representing a net debt to equity ratio 
of 0.06 (Out of which, debt worth US$ 69.0 Mn is foreign currency denominated).
 Particulars (₹ Mn) Q2 FY25 Q2 FY26
Total Operating Revenue 13,667 16,438
Consumption 2,894 3,222
Doctors Expenses 2,380 2,549
Employee (Excluding Doctors) Expenses 2,760 2,991
Other Admin Expenses 2,546 3,607
Total Expenses 10,579 12,369
Other Income 235 240
EBITDA(4)                                  3,323 4,309
Exceptional item(4) - 44
Depreciation and Amortization 647 875
Finance Costs 351 423
Share of (loss)/profit of equity accounted 
investees - (13)
PBT 2,325 2,955
Tax Expense 332 372
PAT 1,993 2,583
Total Comprehensive Income 2,041 3,279
Profit and Loss Statement(1) Key Balance Sheet Items(1)
Particulars 30th Sep 2025
Shareholder Equity 40,619
Total Borrowings 21,355 
Lease Liability 2,048 
Net Block + CWIP (2) 40,818
Goodwill 1,204
Right to Use Assets 2,102
Net Receivables 5,864
Current Investments 13,057
Cash and Bank Balance 5,180
13
14
5,750 215 350 220 350 300 100 400 7,685 
30-Sep-25 HSR 
Bangalore
Rajarhat 
Kolkata
Central 
Bangalore
South
Bangalore
Raipur South West
Bangalore
Pipeline FY30
Expansion: Progress Status & Capex Strategy
Building to strengthen our presence in flagship regions
14
Location Type No. of Beds Project Cost (₹ Mn) Completion Current Status
HSR, Bangalore Greenfield 215 4,900 FY28 Sanctions in place, Project is progressing as per schedule.
Rajarhat, Kolkata Greenfield 350 9,000 FY28 Sanctions in place, Project is progressing as per schedule.
Central Bangalore Lease 220 1,600 FY28 Lease & Construction Agreement is executed; design and 
approvals are in process.
South Bangalore Greenfield 350 8,000 FY29 Design and approvals are in process.
Raipur Expansion 300 5,400 FY28 Sanctions in place, Project is progressing as per schedule.
South-West 
Bangalore Lease 100 840 FY27 Structural work completed, MEP and interior works in progress.
Current Bed Capacity Bed Capacity Addition Bed Capacity Target
Capex Head FY26 (P) FY26 (A)
Greenfield/
Inorganic 4,240 166
Brownfield/ 
Capacity Addition 159 82
Replacement/
Maintenance 2,865 1,016
Cayman 457 451
7,600+
Digital Transformation Initiatives
15
Impact | Mobile Apps
 Initiatives | Business
 GTM | ATHMA
• Completed the first fully digital 
Nursing Excellence Audit at Narayana 
Institute of Cardiac Sciences, 
Bengaluru
• NH patient app crosses 3.5 Mn overall 
installs with an Appstore rating of 4.9/5
• ~40% of install-base are active monthly on 
the app 
• Incident Management achieves 50% 
reduction in reported patient incidents
• AI Lab Insights enabled for advanced 
ICU care.
• GST Bachat Utsav – Sep’25 – Seamless 
transition to new national GST guidelines
• Kiosk – Crossed 100k bookings/month on 
patient Kiosks
• India: 200 beds added
• 20+ Units using ATHMA in the 
domestic market
• Service Rendering Management rolled-
out in Kenya
• Saudi compliant Patient Portal enabled 
Launch | New Products
• Digital Consent for general consent from 
the patients rolled out across various units
• 5000+ Tumor Board conducted digitally 
since launch
• Tablet-first EMR intelligence platform 
launched to enhance clinical decision-
making.
•Incident Management achieved 50% reduction in patient incidents.
NH ESG Vision – “Health For All”
16
16
A Healthy Society
By  improving access to care, digitising patient safety & experience and building the workforce for tomorrow
25,000+ 
Doctors, nurses, 
and paramedical 
trained by 2030
Digitization
For enhancing 
patient safety 
& experience
5000+ 
Bridging care gaps with 
5000 BMTs by 2030
3400 free pediatric heart 
procedures annually
10000+ 
Bright underprivileged 
students aiming to be 
doctors by 2030
Touching lives of 
50,000+ 
Supporting govt. 
school children with 
hygiene and 
nutrition by 2030
5,60,000+ hours
Associate upskilling 
and development 
hours by 2030
A Healthy Institution- 
By fostering a culture of innovation & strong governance
100% 
NABH & enterprise 
level JCI recertified 
hospitals by 2026
Industry leader Best in Class risk 
management
Robust Risk 
Management Process
Cyber resilience
Zero Trust Architecture 
by 2026
1200+ peer-reviewed indexed 
publications (2025–2030)
1000+ Publications
In clinical 
Governance
A Healthy Planet
By being conscious about impact on the environment, prioritizing consumption efficiency and resource optimization
Renewable energy 
(Electricity) mix by 2030
50% Carbon Neutral
By 2040 Waste-water recycling by 2030
Water Consumption 
per occupied bed/day
100% Optimized
Waste management processes
BMW Generation
 per occupied bed/day
30% less 
Paper use across patients 
by 2026 from 2023
On Plan (T 1000) 959 (T 1474) 7846 (T 5950) 1765 (T 1925)
5.15 Pages/ Patient 
YTD  (T 5.10)
On Plan Ongoing
118 Publications  (T 100)On Plan Ongoing On Plan Ongoing On Plan OngoingOn Plan Ongoing
Ongoing 1.41 KL Water Per 
occupied bed (T 1.23)
1.88 KGs Per occupied 
bed (T 1.69)
36% (T 36%)
1.30 L Person Hours 
of training (T 1.95 L) 
Actuals FY 25~26-Upto Q2 (T – Target  FY 25~26-Upto Q2)
Shareholding Pattern
As on 30th Sep 2025(1)
Key DIIs
Nippon Life India Asset Management 
Axis Asset Management
Parag Parikh Asset Management
SBI Life Insurance Co. Ltd.
DSP Asset Management
Unifi Capital
(1) Percentages might not add up to 100% due to rounding off
Total Number of Shares
204,360,804
17
Promoter 
Group 
63.9%
Others 
15.8%
FIIs 
10.5%
DIIs 
9.2%
ESOP Trust 
0.7%
Key FIIs
Vanguard Index Funds
Franklin Templeton Investment Funds
Simcah Partners LP
iShares by Blackrock
Government Pension Fund Global
Kuwait Investment Authority Fund 
Disclaimer and Contact Details
No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or 
correctness of such information or opinions contained herein. The information contained in this presentation is only current as of its date. Certain 
statements made in this presentation may not be based on historical information or facts and may be  “forward looking statements”, including those 
relating to the Company’s general business plans and strategy, its future financial condition and growth prospects, and future developments in its 
industry and its competitive and regulatory environment. 
Actual results may differ materially from these forward-looking statements due to a number of factors, including future changes or developments in the 
Company’s business, its competitive environment and political, economic, legal and social conditions in India.
This communication is for general information purpose only, without regard to specific objectives, financial situations and needs of any particular 
person. This presentation does not constitute an offer or invitation to purchase or subscribe for any shares in the Company and neither any part of it 
shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. The Company may alter, modify or otherwise 
change in any manner the content of this presentation, without obligation to notify any person of such revision or changes. This presentation can not be 
copied and/or disseminated in any manner.
For further Information, please contact :
Mr. Nishant Singh
Vice President – Finance, Investor Relations, M&A
+91 8369353821
nishant.singh@narayanahealth.org
Mr. Vivek Agarwal
Senior Manager –  Investor Relations, M&A
+91 9510756827
vivek.agarwal@narayanahealth.org
investorrelations@narayanahealth.org          |              www.narayanahealth.org 
18
18
19
